Cannabidiol in Patients With COVID-19 and Cardiovascular Disease or Risk Factors
Clinical trial NCT04615949 · TERMINATED
Trial details
- NCT number
- NCT04615949
- Sponsor
- Cardiol Therapeutics Inc.
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-30
- Primary completion
- 2022-11-30
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.